ADDITIONAL INFO

Cagrilintide — Research Peptide

Cagrilintide is a long-acting synthetic analogue of amylin, a hormone co-secreted with insulin that helps regulate appetite, glucose metabolism, and energy balance. It is studied in laboratory and clinical research for its potential applications in obesity and type 2 diabetes models, both as a standalone compound and in combination with GLP-1 receptor agonists such as semaglutide (a combination referred to as CagriSema). Preclinical and early clinical studies suggest effects on appetite signaling, body weight regulation, and metabolic pathways.

Product Details

• Compound Name: Cagrilintide

• Compound Type: Synthetic amylin analogue peptide

• Net Contents: 10 mg lyophilized peptide powder per vial (batch-dependent) (3mL)

• Form: Lyophilized (freeze-dried) powder

• Primary Targets: Amylin receptor pathways

• Research Applications: Appetite regulation, glucose metabolism, energy balance, obesity and type 2 diabetes studies

• Purity: ≥99% (HPLC tested; Certificate of Analysis available)

• Manufactured in: GMP-compliant facility

• Intended Use: Laboratory research use only — not for human or veterinary use

Research Applications
Cagrilintide is commonly used in laboratory models to study:

• Amylin receptor signaling and appetite pathways

• Glucose metabolism and insulin-associated pathways

• Energy balance and weight regulation

• Combination therapies with GLP-1 receptor agonists (e.g., CagriSema)

• Preclinical metabolic and obesity-related research

Storage & Handling

• Store sealed vials at −20 °C prior to reconstitution

• Keep dry and protected from light

• Refrigerate at 2–8 °C after reconstitution

• Avoid repeated freeze–thaw cycles

• Handle using standard laboratory sterile technique

Research Use Notice:
Supplied strictly for laboratory research purposes only. Not intended for human consumption, medical, diagnostic, or therapeutic applications.